Current Staff
- Director: Benjamin Anderson, MD
- Supervisor: Sara Putala, BA
- Clinical Research Associate: Megan Calderado, LMFT
- Clinical Research Assistant: Bruno Casanova, MS
- Clinical Research Assistant: Lindsay Bernier, BS
- Investigator: Tonya Ruggieri, MD
Overview
Psychiatric clinical trials are highly regulated research studies using human volunteers to test the safety and efficacy of novel psychiatric drugs and treatments. Clinical trials are essential for developing new methods to prevent, diagnose, and treat psychiatric disorders. By participating in a clinical trial, patients can take an active role in managing their symptoms, gain access to novel research treatments before they are widely available, and help others by advancing our scientific understanding of the causes and contributors of psychiatric conditions.
CLINICAL TRIALS UNIT
The Clinical Trials Unit is located on the Hartford Hospital / Institute of Living campus in Hartford, CT. The service, directed by Dr. Benjamin Anderson, conducts controlled, clinical testing in human subjects of investigational psychiatric drugs, therapeutic modalities, or combined treatments that are currently in development but not yet approved for use in routine clinical care. Investigational drugs and/or treatments can only be administered to eligible individuals who are enrolled in a formal research study.
All research and clinical studies at the Clinical Trials Unit are conducted under investigator-initiated or industry-sponsored protocols with financial support from pharmaceutical companies, government agencies, and/or non-profit entities. The Hartford Healthcare Institutional Review Board, in conjunction with study sponsors and regulatory authorities, reviews, approves, and oversees all research and clinical trials at the Clinical Trials Unit.
Below you can find more information about currently running research and clinical trials and participant eligibility criteria. If you or a loved one are interested in participating in a research or clinical trial, please contact us by calling 860.545.7476.
Participate in a Clinical Trial
Our current and upcoming studies are listed below. For more information or to see if you or your loved one are eligible to participate in an ongoing or upcoming study, please email us at clinical.trials@hhchealth.org or call us 860-545-7476. We look forward to hearing from you.
Clinical Trials - Recruiting Participants
SCHIZOPHRENIA AND BIPOLAR DISORDER IN PEDIATRIC PATIENTS
ALKS 3831-A312 (Alkermes) CURRENTLY RECRUITING PARTICIPANTS
Has your child recently been diagnosed with schizophrenia or bipolar I disorder? They may be eligible for this study!
This is a clinical study to assess weight gain in pediatric patients with schizophrenia and bipolar I disorder after treatment with olanzapine and samidorphan.
Qualified participants include:
- Children/Teens ages 10-17
- Have been diagnosed with schizophrenia or bipolar I disorder
- Patients who have recently started treatment with olanzapine, are currently experiencing an inadequate response to an antipsychotic or had an inadequate response to at least 1 antipsychotic medication in the past
Those that qualify will:
- Receive study-related care and medications at no cost
- Reimbursement for travel or other expenses may be provided
For more information, contact clinical.trials@hhchealth.org or call us 860.545.7476
|
SCHIZOPHRENIA
CT-155-R-001 (Click Therapeutics) CURRENTLY RECRUITING PARTICIPANTS
Have you been diagnosed with schizophrenia and are experiencing negative symptoms? This study may be for you!
This is a research study to assess the safety and efficacy of a digital therapeutic in adults with negative symptoms of schizophrenia.
Qualified participants include:
- Adults ages 18 and older
- Have been diagnosed with schizophrenia
- Are on a stable dose of antipsychotic medication(s) for at least 12 weeks
Those that qualify will:
- Receive study-related care at no cost
- Reimbursement for travel or other expenses may be provided
For more information, contact clinical.trials@hhchealth.org or call us 860.545.7476
|
MAJOR DEPRESSIVE DISORDER
382-201-00001 (Otsuka) CURRENTLY RECRUITING PARTICIPANTS
Have you been diagnosed with major depressive disorder and are currently experiencing a depressive episode? This study may be for you!
This is a clinical study to assess the efficacy and safety of SEP-363856 as an adjunctive treatment in participants with major depressive disorder.
Qualified participants include:
- Adults ages 18-65
- Have been diagnosed with major depressive disorder
- Have had an inadequate response to 1 but no more than 3 antidepressant medications
Those that qualify will:
- Receive study-related care at no cost
- Reimbursement for travel or other expenses may be provided
For more information, contact clinical.trials@hhchealth.org or call us at 860.545.7476
|
Clinical Trials - Currently Active
SCHIZOPHRENIA
BI 1346-0011 (Boehringer-Ingelheim) CURRENTLY ACTIVE
Have you been diagnosed with schizophrenia and find it difficult to complete daily tasks? This study may be for you!
This is a clinical study to assess safety and efficacy of once-daily Iclepertin in adults with cognitive impairment in schizophrenia.
Qualified participants include:
- Adults ages 18 and older
- Have been diagnosed with schizophrenia
- Have had difficulty remembering things and completing daily tasks associated with schizophrenia
Those that qualify will:
- Receive study-related care and medications at no cost
- Reimbursement for travel or other expenses may be provided
For more information, contact clinical.trials@hhchealth.org or call us 860.545.7476
|
Upcoming Clinical Trials
NO UPCOMING CLINICAL TRIALS
|
Back to Top